PATENT CLAIM ANALYSIS

Application Number: 15895636
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["424", "150100"]

Abstract:
In one aspect, the present invention is directed to a method for preventing or treating necrotic enteritis by administering a hyperimmunized egg product obtained from an egg-producing animal to an avian. The hyperimmunized egg product may contain an antibody specific to an antigen selected from the group consisting of  Clostridium perfringens  α-toxin,  Clostridium perfringens  elongation factor Tu (EF-Tu),  Clostridium perfringens  necrotic enteritis B-like (NetB) toxin,  Clostridium perfringens  Pyruvate: Ferredoxin oxidoreductase (PFO), and  Eimeria tenella  elongation factor 1-alpha.

Claim (Index 13):
The hyperimmunized egg of  claim 11 , wherein the level of antibodies to  Clostridium perfringens  elongation factor Tu (EF-Tu) and  Clostridium perfringens  necrotic enteritis B-like (NetB) toxin in the hyperimmunized egg product is increased relative to the egg from the animal that has not been hyperimmunized.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 88.0
- Lexical Diversity: 1.4918
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15033793', '14044546', '14608577', '11405198', '15616724']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7633279125472292
- 35 USC 102 Novelty (BERT): 0.5378473540380354
- Combined Prediction Score: 0.7407798566963099
- Mean Citation Score: 335.2548740000001
- Max Citation Score: 375.56476
- Similarity Product: 242.859652126174

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test